Reprints Desk CEO Peter Derycz to explore convergence of literature solutions for research, medical information, pharmacovigilance, regulatory affairs, and business intelligence.
Encino, Calif., September 25, 2012– Reprints Desk, Inc., creators of the Article Galaxy article supply system and the all-in-one scientific and technical document management solution Bibliogo, today announced that Reprints Desk’s founder and CEO Peter Derycz will explore the convergence of scientific software and services at the 2012 Pharma-Bio-Med & Competitive Intelligence exposition in Lisbon, Portugal. The presentation takes place Tuesday, October 2nd at 11:55 a.m.
“The number and diversity of STM information services and suppliers for pharmacovigilance, regulatory affairs and medical information has remained fairly static until recently,” said Ian Palmer, Head of Sales & Marketing at Reprints Desk. “A significant convergence is occurring, however, driven by continued information industry mergers and acquisitions, as well as customers’ procurement demands for one-stop shop solutions that deliver efficiencies in both workflow and spending.”
The annual Pharma-Bio-Med & CI event, produced by the International Institute for Information Professionals, is the annual event in Europe that is tailored to the interests of information, library, knowledge management and informatics practitioners working with competitor intelligence and bioscience data information in industries such as pharmaceuticals and biotechnology, food, nutrition, agriculture/crop science cosmetics, medical diagnostics and devices, academic and government health sciences fields.
Reprints Desk is the creator of Article Galaxy, the journal article platform that improves processes and spending related to evidence-based promotions and scientific, technical and medical research. The company is also the creator of Bibliogo, winner of the Software & Information Industry Association (SIIA) 2012 CODiE Award for best online science or technology service.
Bibliogo provides workgroups and professionals in life sciences, engineering-related industries, and others, to save time by simplifying workflows and to reduce costs by eliminating the needs for redundant systems. Bibliogo features include:
- Reference management with auto-assisted curation
- Aggregated alerting & intelligence monitoring
- Collaborative writing for publications
- Personal & workgroup document collections
- Fast document delivery & reprints ordering
- Compliant external article distribution
- And coming soon - discovery via full-text search
For more information about the Pharma-Bio-Med Conference and Exposition, visit the event website online at http://www.pharma-bio-med.com. For more information about Reprints Desk, visit www.reprintsdesk.com. For an online tour and more information about Bibliogo, visit www.bibliogo.com.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard.
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.